This Tata Group Inventory engaged in engaged in designing, manufacturing, and retailing a variety of life-style merchandise, together with watches, jewelry, eyewear, and fragrances, catering to each home and worldwide markets, jumped 5% after the corporate reported March quarterly outcomes with a 19.37 % YOY enhance in income and introduced a 1,one hundred pc dividend.
With a market capitalization of Rs. 3,11,098.03 crores, the share of Titan Firm Restricted has reached an intraday excessive of Rs. 3,530 per fairness share, rising almost 4.95 % from its earlier day’s shut value of Rs. 3,363.45. Since then, the inventory has retreated and is at present buying and selling at Rs. 3,504.20 per fairness share.
Coming into the quarterly outcomes of Titan Firm Restricted, the corporate’s consolidated income from operations elevated by 19.39 % YOY, from Rs. 12,494 crore in This fall FY24 to Rs. 14,916 crore in This fall FY25, and decreased by 15.92 % QoQ from Rs. 17,740 crore in Q3 FY25.
Titan Firm Restricted generated 88.17 % of its income from jewelry gross sales, 7.54 % from watches and wearables, 1.28 % from eyecare, and the remaining 3.01 % from different working actions in This fall FY25. The corporate generated 95.54 % of its income from India and 4.46 % from the remainder of the world in This fall FY25.
In This fall FY25, Titan Firm Restricted’s consolidated web revenue elevated by 12.97 % YOY, reaching Rs. 871 crore in comparison with Rs. 771 crore throughout the identical interval final 12 months. As in comparison with Q3 FY25, the online revenue has decreased by 16.81 %, from Rs. 1,047 crore. The fundamental earnings per share elevated by 12.87 % and stood at Rs. 9.82 as in opposition to Rs. 8.70 recorded in the identical quarter within the earlier 12 months, 2024.
Dividend: The Titan Firm board of administrators has advisable paying a closing dividend on the price of 1,one hundred pc on the face worth of paid-up fairness shares of Re. 1 every for the monetary 12 months 2024-25, which is a dividend of Rs. 11 per fairness share. The fee shall be made after 7 days from the date of the Annual Normal Assembly (AGM).
FY25 Outcomes: Titan Firm Restricted’s income has elevated from Rs. 51,084 crore in FY24 to Rs. 60,456 crore in FY25, which is a development of 18.35 %. The online revenue has decreased by 4.55 %, from Rs. 3,496 crore in FY24 to Rs. 3,337 crore in FY25.
Additionally learn: Blackstone owned inventory jumps 5% after reporting 673% YoY web revenue development; Declares 125% dividend
Administration Commentary and Steerage
Titan’s administration is optimistic concerning the firm’s efficiency within the jewelry phase for the monetary 12 months 2026, anticipating a development of 15-20 % and a margin of 11-11.5 %.
Titan’s CFO, Ashok Sonthalia, expressed confidence within the outlook regardless of ongoing exterior challenges. He stated, “Whereas there have been many exterior challenges, which proceed and typically get aggravated, so far as the outlook goes, it seems like we are able to nonetheless ship a 15% to twenty% development quantity for FY26.”
He additional added, “We’ve got made strategic modifications to collections and pricing, and we’re seeing the outcomes. We anticipate that to enhance additional in FY26. Fragrances are additionally doing effectively,” indicating sturdy efficiency throughout key product segments.
Goal: CLSA has given Titan Firm Restricted an “Outperform” score, revising its goal value barely decrease from Rs. 4,402 to Rs. 4,326 per share. Regardless of the downward revision, this nonetheless displays a powerful upside of 29.13 % from right now’s low of Rs. 3,350.05.
Equally, Citi has maintained a “Impartial” score on Titan whereas elevating its goal value from Rs. 3,550 to Rs. 3,800 per share. This up to date goal implies an upside of 13.43 % from right now’s low of Rs. 3,350.05, indicating average optimism amid cautious sentiment.
Written By – Nikhil Naik
Disclaimer
The views and funding suggestions expressed by funding specialists/broking homes/score companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a threat of monetary losses. Buyers should due to this fact train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the creator aren’t accountable for any losses brought on on account of the choice based mostly on this text. Please seek the advice of your funding advisor earlier than investing.
